FULL TEST BANK FOR
CURRENT MEDICAL DIAGNOSIS AND TREATMENT 2025 64TH EDITION
BY MAXINE A. PAPADAKIS ,MICHAEL W. RABOW, KENNETH R. MCQUAID, MONICA GANDHI
,TABLE OF CONTENTS
CHAPTER 1. DISEASE PREVENTION & HEALTH PROMOTION ...................................................... 4
CHAPTER 1. DISEASE PREVENTION ANSWER SECTION ......................................................... 13
CHAPTER 1 HEALTH PROMOTION (PART 2) ............................................................................... 18
CHAPTER 1. HEALTH PROMOTION (PART 2) ANSWER SECTION ........................................... 25
CHAPTER 2. COMMON SYMPTOMS .......................................................................................... 29
CHAPTER 3. PREOPERATIVE EVALUATION & PERIOPERATIVE MANAGEMENT ......................... 35
CHAPTER 4. GERIATRIC DISORDERS .......................................................................................... 73
CHAPTER 5. PALLIATIVE CARE & PAIN MANAGEMENT ............................................................. 85
CHAPTER 6. DERMATOLOGIC DISORDERS ............................................................................... 112
CHAPTER 7. DISORDERS OF THE EYES & LIDS ......................................................................... 124
CHAPTER 8. EAR, NOSE, & THROAT DISORDERS ..................................................................... 148
CHAPTER 9. PULMONARY DISORDERS .................................................................................... 160
CHAPTER 10. HEART DISEASE.................................................................................................. 184
CHAPTER 11. SYSTEMIC HYPERTENSION................................................................................. 208
CHAPTER 12. BLOOD VESSEL & LYMPHATIC DISORDERS ........................................................ 220
CHAPTER 13. BLOOD DISORDERS ............................................................................................ 231
CHAPTER 14. DISORDERS OF HEMOSTASIS, THROMBOSIS, & ANTITHROMBOTIC THERAPY . 243
CHAPTER 15. GASTROINTESTINAL DISORDERS ....................................................................... 268
CHAPTER 16. LIVER, BILIARY TRACT, & PANCREAS DISORDERS .............................................. 293
CHAPTER 17. BREAST DISORDERS ........................................................................................... 306
CHAPTER 18. GYNECOLOGIC DISORDERS ................................................................................ 318
CHAPTER 19. OBSTETRICS & OBSTETRIC DISORDERS ............................................................. 330
CHAPTER 20. RHEUMATOLOGIC, IMMUNOLOGIC, & ALLERGIC DISORDERS .......................... 345
CHAPTER 21. ELECTROLYTE & ACID-BASE DISORDERS ............................................................ 369
CHAPTER 22. KIDNEY DISEASE ................................................................................................ 382
CHAPTER 23. UROLOGIC DISORDERS ...................................................................................... 409
CHAPTER 24. NERVOUS SYSTEM DISORDERS.......................................................................... 423
,CHAPTER 25. PSYCHIATRIC DISORDERS................................................................................... 449
CHAPTER 26. ENDOCRINE DISORDERS .................................................................................... 469
CHAPTER 27. DIABETES MELLITUS & HYPOGLYCEMIA ............................................................ 494
CHAPTER 28. LIPID DISORDERS ............................................................................................... 508
CHAPTER 29. NUTRITIONAL DISORDERS ................................................................................. 513
CHAPTER 30. COMMON PROBLEMS IN INFECTIOUS DISEASES & ANTIMICROBIAL THERAPY 525
CHAPTER 31. HIV INFECTION & AIDS ...................................................................................... 533
CHAPTER 32. VIRAL & RICKETTSIAL INFECTIONS .................................................................... 546
CHAPTER 33. BACTERIAL & CHLAMYDIAL INFECTIONS........................................................... 551
CHAPTER 34. SPIROCHETAL INFECTIONS ................................................................................ 558
CHAPTER35 PROTOZOAL & HELMINTHIC INFECTIONS ........................................................... 565
CHAPTER 36. MYCOTIC INFECTIONS ....................................................................................... 568
CHAPTER 37. DISORDERS RELATED TO ENVIRONMENTAL EMERGENCIES .............................. 570
CHAPTER38. POISONING......................................................................................................... 576
CHAPTER 39. CANCER ............................................................................................................. 579
CHAPTER 40. GENETIC & GENOMIC DISORDERS .................................................................... 593
CHAPTER 41.ORTHOPEDIC DISORDERS & SPORTS MEDICINE ................................................ 622
CHAPTER 42. LESBIAN, GAY, BISEXUAL, & TRANSGENDER HEALTH ........................................ 630
, CHAPTER 1. DISEASE PREVENTION & HEALTH PROMOTION
1. WHICH OF THE FOLLOWING BEHAVIORS INDICATES THE HIGHEST POTENTIAL FOR SPREADING
INFECTIONS AMONG CLIENTS? THE NURSE:
1) DISINFECTS DIRTY HANDS WITH ANTIBACTERIAL SOAP.
2) ALLOWS ALCOHOL-BASED RUB TO DRY FOR 10 SECONDS.
3) WASHES HANDS ONLY AFTER LEAVING EACH ROOM.
4) USES COLD WATER FOR MEDICAL ASEPSIS.
2. WHAT IS THE MOST FREQUENT CAUSE OF THE SPREAD OF INFECTION AMONG
INSTITUTIONALIZED
PATIENTS?
1) AIRBORNE MICROBES FROM OTHER PATIENTS
2) CONTACT WITH CONTAMINATED EQUIPMENT
3) HANDS OF HEALTHCARE WORKERS
4) EXPOSURE FROM FAMILY MEMBERS
3. WHICH OF THE FOLLOWING NURSING ACTIVITIES IS OF HIGHEST PRIORITY FOR MAINTAINING
MEDICAL ASEPSIS?
1) WASHING HANDS
2) DONNING GLOVES
3) APPLYING STERILE DRAPES
4) WEARING A GOWN
4. A PATIENT INFECTED WITH A VIRUS BUT WHO DOES NOT HAVE ANY OUTWARD SIGN OF THE
DISEASE IS CONSIDERED A:
CURRENT MEDICAL DIAGNOSIS AND TREATMENT 2025 64TH EDITION
BY MAXINE A. PAPADAKIS ,MICHAEL W. RABOW, KENNETH R. MCQUAID, MONICA GANDHI
,TABLE OF CONTENTS
CHAPTER 1. DISEASE PREVENTION & HEALTH PROMOTION ...................................................... 4
CHAPTER 1. DISEASE PREVENTION ANSWER SECTION ......................................................... 13
CHAPTER 1 HEALTH PROMOTION (PART 2) ............................................................................... 18
CHAPTER 1. HEALTH PROMOTION (PART 2) ANSWER SECTION ........................................... 25
CHAPTER 2. COMMON SYMPTOMS .......................................................................................... 29
CHAPTER 3. PREOPERATIVE EVALUATION & PERIOPERATIVE MANAGEMENT ......................... 35
CHAPTER 4. GERIATRIC DISORDERS .......................................................................................... 73
CHAPTER 5. PALLIATIVE CARE & PAIN MANAGEMENT ............................................................. 85
CHAPTER 6. DERMATOLOGIC DISORDERS ............................................................................... 112
CHAPTER 7. DISORDERS OF THE EYES & LIDS ......................................................................... 124
CHAPTER 8. EAR, NOSE, & THROAT DISORDERS ..................................................................... 148
CHAPTER 9. PULMONARY DISORDERS .................................................................................... 160
CHAPTER 10. HEART DISEASE.................................................................................................. 184
CHAPTER 11. SYSTEMIC HYPERTENSION................................................................................. 208
CHAPTER 12. BLOOD VESSEL & LYMPHATIC DISORDERS ........................................................ 220
CHAPTER 13. BLOOD DISORDERS ............................................................................................ 231
CHAPTER 14. DISORDERS OF HEMOSTASIS, THROMBOSIS, & ANTITHROMBOTIC THERAPY . 243
CHAPTER 15. GASTROINTESTINAL DISORDERS ....................................................................... 268
CHAPTER 16. LIVER, BILIARY TRACT, & PANCREAS DISORDERS .............................................. 293
CHAPTER 17. BREAST DISORDERS ........................................................................................... 306
CHAPTER 18. GYNECOLOGIC DISORDERS ................................................................................ 318
CHAPTER 19. OBSTETRICS & OBSTETRIC DISORDERS ............................................................. 330
CHAPTER 20. RHEUMATOLOGIC, IMMUNOLOGIC, & ALLERGIC DISORDERS .......................... 345
CHAPTER 21. ELECTROLYTE & ACID-BASE DISORDERS ............................................................ 369
CHAPTER 22. KIDNEY DISEASE ................................................................................................ 382
CHAPTER 23. UROLOGIC DISORDERS ...................................................................................... 409
CHAPTER 24. NERVOUS SYSTEM DISORDERS.......................................................................... 423
,CHAPTER 25. PSYCHIATRIC DISORDERS................................................................................... 449
CHAPTER 26. ENDOCRINE DISORDERS .................................................................................... 469
CHAPTER 27. DIABETES MELLITUS & HYPOGLYCEMIA ............................................................ 494
CHAPTER 28. LIPID DISORDERS ............................................................................................... 508
CHAPTER 29. NUTRITIONAL DISORDERS ................................................................................. 513
CHAPTER 30. COMMON PROBLEMS IN INFECTIOUS DISEASES & ANTIMICROBIAL THERAPY 525
CHAPTER 31. HIV INFECTION & AIDS ...................................................................................... 533
CHAPTER 32. VIRAL & RICKETTSIAL INFECTIONS .................................................................... 546
CHAPTER 33. BACTERIAL & CHLAMYDIAL INFECTIONS........................................................... 551
CHAPTER 34. SPIROCHETAL INFECTIONS ................................................................................ 558
CHAPTER35 PROTOZOAL & HELMINTHIC INFECTIONS ........................................................... 565
CHAPTER 36. MYCOTIC INFECTIONS ....................................................................................... 568
CHAPTER 37. DISORDERS RELATED TO ENVIRONMENTAL EMERGENCIES .............................. 570
CHAPTER38. POISONING......................................................................................................... 576
CHAPTER 39. CANCER ............................................................................................................. 579
CHAPTER 40. GENETIC & GENOMIC DISORDERS .................................................................... 593
CHAPTER 41.ORTHOPEDIC DISORDERS & SPORTS MEDICINE ................................................ 622
CHAPTER 42. LESBIAN, GAY, BISEXUAL, & TRANSGENDER HEALTH ........................................ 630
, CHAPTER 1. DISEASE PREVENTION & HEALTH PROMOTION
1. WHICH OF THE FOLLOWING BEHAVIORS INDICATES THE HIGHEST POTENTIAL FOR SPREADING
INFECTIONS AMONG CLIENTS? THE NURSE:
1) DISINFECTS DIRTY HANDS WITH ANTIBACTERIAL SOAP.
2) ALLOWS ALCOHOL-BASED RUB TO DRY FOR 10 SECONDS.
3) WASHES HANDS ONLY AFTER LEAVING EACH ROOM.
4) USES COLD WATER FOR MEDICAL ASEPSIS.
2. WHAT IS THE MOST FREQUENT CAUSE OF THE SPREAD OF INFECTION AMONG
INSTITUTIONALIZED
PATIENTS?
1) AIRBORNE MICROBES FROM OTHER PATIENTS
2) CONTACT WITH CONTAMINATED EQUIPMENT
3) HANDS OF HEALTHCARE WORKERS
4) EXPOSURE FROM FAMILY MEMBERS
3. WHICH OF THE FOLLOWING NURSING ACTIVITIES IS OF HIGHEST PRIORITY FOR MAINTAINING
MEDICAL ASEPSIS?
1) WASHING HANDS
2) DONNING GLOVES
3) APPLYING STERILE DRAPES
4) WEARING A GOWN
4. A PATIENT INFECTED WITH A VIRUS BUT WHO DOES NOT HAVE ANY OUTWARD SIGN OF THE
DISEASE IS CONSIDERED A:
